Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study - The Lancet Oncology
Wellington Management, Inc. | LinkedIn
MET Group enters the German market with gas storage and sales activities
Message from the Management - MET Germany
Metabolic equivalents (MET) of various activities* | Download Table
MET Group
MET Management GmbH | Implisense
Interim CEO for a manufacturing company in the USA | Atreus GmbH
TCM International Tool Consulting & Management GmbH
SMS group GmbH: Swiss Steel Emmenbrücke has awarded MET/Con the order to supply a PQA® for quality management along the complete production chain | Press Detail